Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Loading vs Clopidogrel Loading and Reloading in STEMI
NCT01961856Phase 3Completed
- Sponsor
- University of Patras
- Start
- Sep 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ticagrelor in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by University of Patras. Primary endpoint: Platelet Reactivity at 24 hours. Started Sep 2013; status: completed.
02
Drugs
ticagrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01961856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01961856.